Development and Validation of Risk Matrices Concerning Ulcerative Colitis Outcomes—Bayesian Network Analysis-Reference-Cited by-同舟云学术

Development and Validation of Risk Matrices Concerning Ulcerative Colitis Outcomes—Bayesian Network Analysis

Published:2018-10-17 Issue:4 Volume:13 Page:401-409
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:

Author:

Magro Fernando¹²³,Dias Cláudia Camila⁴⁵,Portela Francisco⁶,Miranda Mário⁶,Fernandes Samuel⁷,Bernardo Sonia⁷,Ministro Paula⁸,Lago Paula⁹,Rosa Isadora¹⁰,Pita Inês¹⁰,Correia Luis⁷,Rodrigues Pedro Pereira⁴⁵^ORCID,

Affiliation:

1. Gastroenterology Department, Hospital São João, Porto, Portugal

2. Institute of Pharmacology and Therapeutics, Faculty of Medicine of the University of Porto, Porto, Portugal

3. Center for Drug Discovery and Innovative Medicines, University of Porto, Porto, Portugal

4. Department of Community Medicine, Information and Health Sciences, Faculty of Medicine of the University of Porto, Porto, Portugal

5. AI4Health group, Center for Health Technology and Services Research, Porto, Portugal

6. Gastroenterology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal

7. Gastroenterology Department, Centro Hospitalar Lisboa Norte, Hospital de Santa Maria, Lisboa, Portugal

8. Gastroenterology Department, Centro Hospitalar Tondela e Viseu, Tondela, Portugal

9. Gastroenterology Department, Centro Hospitalar do Porto, Porto. Portugal

10. Gastroenterology Department, Instituto Português de Oncologia de Lisboa, Lisboa, Portugal

Funder

Grupo de Estudo da Doença Inflamatória Intestinal

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/13/4/401/28251238/jjy168.pdf

Reference31 articles.

1. Ulcerative colitis;Ordás;Lancet,2012

2. Ulcerative colitis;Adams;Am Fam Physician,2013

3. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders;Magro;J Crohns Colitis,2017

4. Ulcerative colitis: epidemiology, diagnosis, and management;Feuerstein;Mayo Clin Proc,2014

5. Colectomy rates in ulcerative colitis are low and decreasing: 10-year follow-up data from the Swiss IBD Cohort Study;Parragi;J Crohns Colitis,2018

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of sex and socioeconomic status on the likelihood of surgery, hospitalization, and use of medications in inflammatory bowel disease: a systematic review and meta-analysis;Systematic Reviews;2024-06-24

2. Comparison of Fecal Calprotectin and Myeloperoxidase in Predicting Outcomes in Inflammatory Bowel Disease;Inflammatory Bowel Diseases;2024-02-28

3. The Influence of Subclinical Active Inflammation on IFX Pharmacokinetic Modeling and Disease Progression Assessment: Findings from a Prospective Real-World Study in Inflammatory Bowel Disease Patients;Journal of Crohn's and Colitis;2024-01-19

4. Impact of age at diagnosis on long‐term prognosis in patients with intestinal Behçet's disease;Journal of Gastroenterology and Hepatology;2023-12-27

5. The Disease Severity Index for Inflammatory Bowel Disease Is a Valid Instrument that Predicts Complicated Disease;Inflammatory Bowel Diseases;2023-12-22